These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 1892370
1. The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys. Kurlan R, Kim MH, Gash DM. Ann Neurol; 1991 Jun; 29(6):677-9. PubMed ID: 1892370 [Abstract] [Full Text] [Related]
2. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism. Kurlan R, Kim MH, Gash DM. Mov Disord; 1991 Jun; 6(2):111-8. PubMed ID: 2057003 [Abstract] [Full Text] [Related]
3. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Miletich RS, Bankiewicz KS, Quarantelli M, Plunkett RJ, Frank J, Kopin IJ, Di Chiro G. Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225 [Abstract] [Full Text] [Related]
4. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS. Front Biosci; 2003 Sep 01; 8():a155-66. PubMed ID: 12957824 [Abstract] [Full Text] [Related]
9. [Spontaneous saccades in MPTP-induced hemi-parkinsonian monkeys]. Usui S, Fukuda H, Hikosaka O. Rinsho Shinkeigaku; 1990 Nov 01; 30(11):1181-9. PubMed ID: 2085922 [Abstract] [Full Text] [Related]
10. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates. Wichmann T, Kliem MA, DeLong MR. Exp Neurol; 2001 Feb 01; 167(2):410-24. PubMed ID: 11161630 [Abstract] [Full Text] [Related]
11. Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. Goldstein DS, Li ST, Holmes C, Bankiewicz K. J Pharmacol Exp Ther; 2003 Sep 01; 306(3):855-60. PubMed ID: 12805479 [Abstract] [Full Text] [Related]
12. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Doudet D, Gross C, Lebrun-Grandié P, Bioulac B. C R Seances Soc Biol Fil; 1985 Sep 01; 179(1):85-97. PubMed ID: 3161601 [Abstract] [Full Text] [Related]
13. [Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model]. Takeda M. Hokkaido Igaku Zasshi; 1995 Nov 01; 70(6):829-38. PubMed ID: 8582706 [Abstract] [Full Text] [Related]
18. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys. Domino EF, Ni L, Zhang H, Kohno Y, Sasa M. J Pharmacol Exp Ther; 1998 Dec 01; 287(3):983-7. PubMed ID: 9864283 [Abstract] [Full Text] [Related]